Tarpon Biosystems was formed to uniquely address critical needs in the biopharmaceutical industry to reduce production costs and add the much-needed flexibility in purification operations. Tarpon has identified and combined unique technologies to provide proprietary, disposable-based technology, which enables the use of highly efficient, low cost industrial purification processes widely employed in other industries. Our technology, called BioSMB™, adapts a proven manufacturing technology for use in the biomanufacturing environment. BioSMBTM systems incorporate disposable components to enable flexible, multi-product biomanufacturing, all at a significantly reduced cost. Tarpon Biosystems' BioSMB technology was developed to be a downstream processing solution that uses disposables in an economically viable way to bring efficiency, flexibility, and practicality to bioprocess. We believe that the key to bringing innovative treatments to patients around the world is by reducing the cost of therapeutics through unparalleled efficiency and flexibility of biopharmaceutical purification. Working together, we can alleviate legacy manufacturing bottlenecks when implementing high titer processes and create a true facility of the future that employs fully disposable process trains. As experts in biomanufacturing, we are dedicated to making new technology easy to implement by partnering with customers and providing a complete line of support services and tools.